// App-Quantinova.ai

: Decreased Plasma Fibrinolytic Potential in Venous Thrombosis Patients Using CloFAL Assay and the Association with Post‐thrombotic Syndrome and Residual Thrombus

Researchers

Presenter

  • I. Macedo Toni

Principal Investigators

  • B. Moraes Martinelli

  • S. Cares Huber

  • M. Pereira Colella

  • S. Lima Montalvao

  • J.M. Annichino-Bizzacchi

  • M. Quintero

Medical Centers

  • State University Campinas, Campinas, Brazil

Locations

  • Brazil

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

  • Blood/haematological Diseases

  • Cardiovascular (CVS)

Disease

  • Venous thrombosis

Biomarkers

  • Serpin E1

  • Thrombin-activatable fibrinolysis inhibitor

  • Tumor necrosis factor

Drug/Treatment

  • Fibrinogen (IV)

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved